In my personal opinion, the Management had a cautious tone in the recent Concall w/ some positives and negatives going forward.
Some notes from the Q2’FY2024 Concall by Management:-
Positives
Product Mix Change:-
This is reflected in improved margins this quarter and will help in product diversification going forward.
New Customer Acquisition for HALS:-
This volume should be reflected in the upcoming quarters for Clean Science
Potential Mean Reversion Play:-
Strategic Capex(30Cr) with Large Revenue(100Cr):-
Negatives
Destocking Pressure to continue:-
This should continue for a couple of quarters
Demand Environment continues to be weak:-
Under performance of Performance Chemical Segment:-
Summary:-
- The valuations of the company continue to be a bit elevated.
- It is a debt free organization with all the planned CAPEX to be funded from internal accruals.
- The overhang of management bringing the stake <75% is done and FII have increased the stake over last 2 quarters in the company.
- Demand environment and destocking situation will potentially result in some headwinds in coming couple of quarters.
Subscribe To Our Free Newsletter |